Jan 28 (Reuters) - Milestone Pharmaceuticals Inc MIST.O:
MILESTONE PHARMACEUTICALS PROVIDES 2025 CORPORATE OUTLOOK AND WILL HOST INVESTOR EVENT ON FEBRUARY 25 IN NYC
MILESTONE PHARMACEUTICALS INC: PDUFA DATE OF MARCH 27, 2025 FOR CARDAMYST™ (ETRIPAMIL) NASAL SPRAY
MILESTONE PHARMACEUTICALS INC: PLANS TO INITIATE PHASE 3 STUDY IN AFIB-RVR IN H1 2025
Source text: ID:nGNX52zbjR
Further company coverage: MIST.O